Navigation Links
Novel way to fight cancer

Scientists feel that they have found a innovative way to fight deadly cancers: increase a patient's immune cells in the laboratory to recognize and fight the patient's own tumor, then inject the cells back into the body and let them go to work.//

Known as adoptive transfer, the experimental technique involves the body's T cells, which are responsible for finding and attacking foreign cells that have entered the body. In the experiment, the scientists extracted some of these cells from 15 patients suffering from the deadly form of skin cancer, melanoma, then exposed them in the laboratory to a small segment of the patient's tumor. The cells learned to recognize the tumor fragment as a foreign body and fight it. Additionally the cells also multiplied, providing enough cells to replace the patient's existing immune system, which had proven ineffective at fighting the cancer on its own.

The researchers then used chemotherapy to destroy the patient's ineffective immune system and replaced it with the T cells grown in the laboratory. In 10 of the 16 patients, the treatment resulted in at least a 62 percent shrinkage of the tumors, with no re-growth or appearance of new tumors. Some tumor disappearance was noted in four other patients. The effects lasted for four months, at which time the patient's own immune system recovered and took over its usual job of fighting infections.

The technique, say the investigators, is a major improvement over past attempts to treat cancer with immune cells. Steven A. Rosenberg, M.D., Ph.D., "In the past, only a fraction of a percent of the cells we injected were able to survive, and they would persist for only a few days." In this study, he continues, "We have been able to generate a very large number of immune cells that appear in the blood and constitute a majority of the immune system of the patient. These persist for over four months and are able to attack the tumor."


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel test for bowel cancer
6. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
7. Novel Therapy for Chronic Problem
8. Blood Sugar Kept In Control By Novel Protein
9. Novel antibiotic dressing developed for improved wound healing
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Novel drug holds promise for treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... United Benefit Advisors (UBA), ... as the latest addition to its family of Partner Firms. Headquartered in Mount ... wellness, human resources, and health care consumerism specialists. , “Partnering with UBA will ...
(Date:5/5/2016)... ... May 05, 2016 , ... An essential ... U.S. states and certain Canadian provinces is now available from the International Association ... (WCRI). , The report, Workers’ Compensation Laws as of January 1, ...
(Date:5/5/2016)... Chicago, IL (PRWEB) , ... May 05, 2016 , ... ... that employers continue to face challenges in getting employees to understand and use the ... (ACA). One of the nation’s leading non-profit business groups of large, self-insured public and ...
(Date:5/5/2016)... ... May 05, 2016 , ... Vitenas Cosmetic Surgery has been ... presented by the American Institute of Architects and the Academy of Architecture for Health. ... Perkins+Will and Harrell Architects, opened to patients in October of 2014. ...
(Date:5/5/2016)... ... 2016 , ... TIME for Kids and The ZAC Foundation – a national ... reach nearly 1 million children with important water safety messages before summer break begins. ... of accidental death in children one to 6 years of age. TIME for ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... DUBLIN , May 5, 2016 /PRNewswire/ ... the addition of the  "Europe Systemic Lupus ... 2016"  report to their offering.  ... The latest research Europe Systemic Lupus ... 2016, provides comprehensive insights into Systemic Lupus ...
(Date:5/4/2016)... Israel , May 4, 2016 ... BiondVax,s CEO, Dr. Ron Babecoff , will be attending ... York City . On Thursday, May 5, ... a conference presented by Joseph Gunner & Co, ... The BiondVax presentation that Dr. Babecoff will be using is ...
(Date:5/4/2016)... , May 4, 2016 Valeritas ... of an alternative public offering (APO). This was accomplished ... company, Valeritas, Inc. and a private placement of approximately ... $5.00 per share. Under the terms of ... 2016, Valeritas Holdings, Inc. will trade on the OTC ...
Breaking Medicine Technology: